Overview
- The French Pediatric Society reports that just 46% of infants born between February and August received the Beyfortus monoclonal antibody.
- Public health surveillance shows Île-de-France in an epidemic phase and Normandy in a pre-epidemic phase, indicating accelerating transmission.
- Maternity services began systematic neonatal Beyfortus administration nationwide on 1 September, with Guyane starting in early August.
- Catch-up doses are available in primary care for the February–August cohort, with only 30% reimbursement by Assurance maladie unless families qualify for C2S or AME or have suitable complementary coverage.
- France’s dual approach pairs maternal vaccination with Abrysvo and infant protection with Beyfortus, which authorities say helped avert thousands of hospitalizations in recent winters.